- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03255291
Communicating Multiple Disease Risks: A Translation of Risk Prediction Science
Epidemiology seeks to improve public health by identifying risk factors for cancer and other diseases and conveying that information to relevant audiences (e.g., physicians, the public). The audience is presumed to understand and use that information to make appropriate decisions about lifestyle behaviors and medical treatments. Yet, even though a single risk factor can affect the risk of multiple health outcomes, this information is seldom communicated to people in a way that optimizes their understanding of the importance of engaging in a single healthy behavior. Providing individuals with the ability to understand how a single behavior (obtaining sufficient physical activity) could affect their risk of developing multiple diseases could foster a more coherent and meaningful picture of the behavior's importance in reducing health risks, increase motivation and intentions to engage in the behavior, and over time improve public health.
The proposed study translates epidemiological data about five diseases that cause significant morbidity and mortality (i.e., colon cancer, breast cancer (women), heart disease, diabetes, and stroke) into a visual display that conveys individualized risk estimates in a comprehensible, meaningful, and useful way to diverse lay audiences.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Missouri
-
Saint Louis, Missouri, United States, 63110
- Washington University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 30-64 years of age
- Less than (3) relevant comorbidities (diabetes, heart disease, stroke, and cancer, where cancer counts as (2) comorbidities for women but (1) for men)
- Having a SMS capable mobile phone that is not shared with anyone else
Exclusion Criteria:
- Not meeting national guidelines for aerobic physical activity (i.e., at least 150 minutes per week of moderate intensity aerobic physical activity)
- Participants from HRPO# 201501028 will be ineligible for this study
- Uses text messaging less than once per month
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Risk Display Format:Risk Ladder:Imagery Behavior:Exercise
|
The App provides participants with personalized risk results for colon cancer, breast cancer (women), heart disease, diabetes, and stroke.
Assesses information comprehension, intentions, perceived risk and severity worry, self- efficacy, response efficacy, affect, race, education, age, numeracy, graph literacy, and exercise and sleep behaviors.
Participants imagine themselves improving exercise
-Reminders to practice mental imagery
-Assesses exercise behavior, intentions, actions plans, self-efficacy, affect, imagery vividness, and practice.
|
|
Experimental: Risk Display Format:Risk Ladder:Imagery Behavior:Sleep
|
The App provides participants with personalized risk results for colon cancer, breast cancer (women), heart disease, diabetes, and stroke.
Assesses information comprehension, intentions, perceived risk and severity worry, self- efficacy, response efficacy, affect, race, education, age, numeracy, graph literacy, and exercise and sleep behaviors.
-Reminders to practice mental imagery
-Assesses exercise behavior, intentions, actions plans, self-efficacy, affect, imagery vividness, and practice.
-Participants imagine themselves improving sleep hygiene
|
|
Experimental: Risk Display Format:Table:Imagery Behavior:Exercise
|
The App provides participants with personalized risk results for colon cancer, breast cancer (women), heart disease, diabetes, and stroke.
Assesses information comprehension, intentions, perceived risk and severity worry, self- efficacy, response efficacy, affect, race, education, age, numeracy, graph literacy, and exercise and sleep behaviors.
Participants imagine themselves improving exercise
-Reminders to practice mental imagery
-Assesses exercise behavior, intentions, actions plans, self-efficacy, affect, imagery vividness, and practice.
|
|
Experimental: Risk Display Format:Table: Imagery Behavior:Sleep
|
The App provides participants with personalized risk results for colon cancer, breast cancer (women), heart disease, diabetes, and stroke.
Assesses information comprehension, intentions, perceived risk and severity worry, self- efficacy, response efficacy, affect, race, education, age, numeracy, graph literacy, and exercise and sleep behaviors.
-Reminders to practice mental imagery
-Assesses exercise behavior, intentions, actions plans, self-efficacy, affect, imagery vividness, and practice.
-Participants imagine themselves improving sleep hygiene
|
|
Experimental: Risk Display Format:Text:Imagery Behavior:Exercise
|
The App provides participants with personalized risk results for colon cancer, breast cancer (women), heart disease, diabetes, and stroke.
Assesses information comprehension, intentions, perceived risk and severity worry, self- efficacy, response efficacy, affect, race, education, age, numeracy, graph literacy, and exercise and sleep behaviors.
Participants imagine themselves improving exercise
-Reminders to practice mental imagery
-Assesses exercise behavior, intentions, actions plans, self-efficacy, affect, imagery vividness, and practice.
|
|
Experimental: Risk Display Format:Text:Imagery Behavior:Sleep
|
The App provides participants with personalized risk results for colon cancer, breast cancer (women), heart disease, diabetes, and stroke.
Assesses information comprehension, intentions, perceived risk and severity worry, self- efficacy, response efficacy, affect, race, education, age, numeracy, graph literacy, and exercise and sleep behaviors.
-Reminders to practice mental imagery
-Assesses exercise behavior, intentions, actions plans, self-efficacy, affect, imagery vividness, and practice.
-Participants imagine themselves improving sleep hygiene
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change From Baseline to 90-day Follow-up in Self Reported Weekly Minutes of Exercise
Time Frame: Baseline and up to 90 days
|
Baseline and up to 90 days
|
|
|
Difference in Gist Comprehension of Risk Information by Risk Display Format
Time Frame: Baseline
|
|
Baseline
|
|
Difference in Verbatim Comprehension of Risk Information by Risk Communication Strategy
Time Frame: Baseline
|
|
Baseline
|
|
Difference in Self-reported Intentions to Engage in Physical Activity by Risk Display Format
Time Frame: Baseline
|
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effect of the Intervention on Physical Activity Levels as Measured by Maintenance Self-efficacy
Time Frame: 90 days
|
|
90 days
|
|
Effect of the Intervention on Physical Activity Levels as Measured by Recovery Self-efficacy
Time Frame: 90 days
|
|
90 days
|
|
Effect of the Intervention on Physical Activity Levels as Measured by Affective Attitudes to Exercise - Enjoying Behavior
Time Frame: 90 days
|
|
90 days
|
|
Effect of the Intervention on Physical Activity Levels as Measured by Affective Attitudes to Exercise - Thinking Behavior is Unpleasant
Time Frame: 90 days
|
|
90 days
|
|
Effect of the Intervention on Physical Activity Levels as Measured by Perceived Vividness of Self-regulatory Imagery
Time Frame: 90 days
|
|
90 days
|
|
Effect of the Intervention on Physical Activity Levels as Measured by Action Planning
Time Frame: 90 days
|
|
90 days
|
|
Effect of the Intervention on Physical Activity Levels as Measured by Coping Planning
Time Frame: 90 days
|
|
90 days
|
|
Effect of the Intervention on Physical Activity Levels as Measured by Action Self-efficacy
Time Frame: 90 days
|
|
90 days
|
Collaborators and Investigators
Investigators
- Principal Investigator: Erika Waters, MPH, Ph.D., Washington University School of Medicine
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 201706063
- R01CA190391 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Danone NutriciaCompletedHealthy Elderly | Healthy VolunteersChina
-
National and Kapodistrian University of AthensCompletedHealthy Adults | Healthy Volunteers OnlyGreece
Clinical Trials on Risk Assessment App
-
Bukret Plastic SurgeryCompletedRisk Factors | Risk AssessmentArgentina
-
University of IbadanUniversity College Hospital, Ibadan; Obafemi Awolowo University Teaching Hospital and other collaboratorsCompletedBreast Cancer | Health Behavior | Health Knowledge, Attitudes, Practice | Health Care Utilization | Risk Reduction BehaviorNigeria
-
Magdi Yacoub Heart FoundationRecruiting
-
Instituto Mexicano del Seguro SocialInstituto Nacional de Salud Publica, Mexico; Centro de Investigación en Matemáticas...Completed
-
Oslo Metropolitan UniversityNorwegian Labour and Welfare AdministrationActive, not recruitingMusculoskeletal Pain DisorderNorway
-
Assistance Publique Hopitaux De MarseilleNot yet recruiting
-
University of AarhusAarhus University Hospital; Herning Hospital; Horsens Hospital; Randers Regional... and other collaboratorsCompleted
-
National Center for AIDS/STD Control and Prevention...UnknownUsing HIV Risk Assessment Tool to Promote HIV Testing Among Men Who Have Sex With Men (online-RASSL)HIV Infections | HIV/AIDS | Social MediaChina
-
Scripps Translational Science InstituteIllumina, Inc.; Optum, Inc.; Quest Diagnostics-Nichols InsituteNot yet recruitingCoronary Artery Disease | Glaucoma
-
Duke UniversityNational Human Genome Research Institute (NHGRI)CompletedLiver Diseases | Cardiovascular Diseases | Cancer | HyperthermiaUnited States